The Degree of Plasma Oxidized Low-Density Lipoprotein Level Decrease Is Related to Clinical Outcomes for Patients with Acute Ischemic Stroke
Open Access
- 14 December 2021
- journal article
- research article
- Published by Wiley in Disease Markers
- Vol. 2021, 1-7
Abstract
Objective. To investigate the relationship between the decrease of plasma oxidized low-density lipoprotein (oxLDL) levels and clinical outcomes in patients with acute atherosclerosis-related ischemic stroke. Methods. We recruited acute ischemic stroke patients within 3 days of onset consecutively. Plasma oxLDL levels were measured on the second day after admission and before discharge (10-14 days after stroke onset). Initial stroke severity was assessed by the National Institutes of Health Stroke Scale (NIHSS) scores, and infarct volume was measured using diffusion-weighted imaging (DWI) by the ITK-SNAP software. Clinical outcomes were evaluated by DWI volumes in the acute phase, neurological improvement at discharge, and favorable functional prognosis at 90 days. Logistic regression was performed to evaluate the association between oxLDL level decrease and clinical outcomes. Results. 207 patients were enrolled in this study. Compared with the mild decrease of the oxLDL level group, patients with a significant decrease of the oxLDL level group were more likely to have a higher ratio of neurological improvement at discharge (55.07% vs. 14.49%, ) and favorable functional prognosis at 90 days (91.30% vs. 55.07%, ). In multivariable logistic regression, the degree of oxLDL level decrease was related to neurological improvement at discharge and favorable functional prognosis at 90 days ( ). Patients with significant decrease were more likely to have neurological improvement at discharge ( , 95% CI, 3.14-19.98, and ) and favorable functional prognosis at 90 days ( , 95% CI, 2.40-23.23, and ) compared to patients with mild decrease of oxLDL level. The DWI volumes in patients with different oxLDL level decrease groups had no statistical difference ( ), and the Spearman’s rho between oxLDL level decrease and DWI infarct volumes was -0.03, but no statistical difference ( ). Conclusions. The degree of oxLDL level decrease is related to neurological improvement at discharge and favorable functional prognosis at 90 days for patients with acute atherosclerosis-related ischemic stroke, but not with infarct volume in the acute phase.Keywords
All Related Versions
Funding Information
- Public Welfare Foundation (AX083CS, 2020WYRCJY04, 2020MZYS09, 2020MWDXK01, 20184Y0178)
- Cultivation of elite talents in Shanghai Fifth People’s Hospital (AX083CS, 2020WYRCJY04, 2020MZYS09, 2020MWDXK01, 20184Y0178)
- Minhang District High-Level Specialist Backbone Physician Training Plan (AX083CS, 2020WYRCJY04, 2020MZYS09, 2020MWDXK01, 20184Y0178)
- Shanghai Minhang District Health and Family Planning Commission for constructing big disciplines (AX083CS, 2020WYRCJY04, 2020MZYS09, 2020MWDXK01, 20184Y0178)
- Shanghai Municipal Health and Family Planning Commission (AX083CS, 2020WYRCJY04, 2020MZYS09, 2020MWDXK01, 20184Y0178)
This publication has 33 references indexed in Scilit:
- Statin therapy reduces oxidized low density lipoprotein level, a risk factor for stroke outcomeCritical Care, 2014
- Soluble Lectin-Like Oxidized Low Density Lipoprotein Receptor-1 as a Biochemical Marker for Atherosclerosis-Related DiseasesDisease Markers, 2013
- LOX-1, OxLDL, and AtherosclerosisMediators of Inflammation, 2013
- Oxidized Low-Density Lipoprotein and AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Acute Blood Pressure Levels and Neurological Deterioration in Different Subtypes of Ischemic StrokeStroke, 2009
- Oxidized Phospholipids, Lp(a) Lipoprotein, and Coronary Artery DiseaseNew England Journal of Medicine, 2005
- Lipids and oxidised lipids in human atherosclerotic lesions at different stages of developmentBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1995
- Pilot randomized trial of tissue plasminogen activator in acute ischemic stroke. The TPA Bridging Study Group.Stroke, 1993
- Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment.Stroke, 1993
- Measurements of acute cerebral infarction: a clinical examination scale.Stroke, 1989